Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-upElisabeth Ejerblad, Gunnar Birgegård, Jürgen Thiele et al.|Hematology|2012Cited by 30